Nadja Zeltner

Athens, GA, United States of America

Nadja Zeltner

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Memorial Sloan Kettering Cancer Center, University of Georgia Research Foundation Inc. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadja Zeltner. Retrieved from https://idiyas.com/inventor/nadja-zeltner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nadja Zeltner: Innovator in Stem Cell Research

Introduction

Nadja Zeltner is a prominent inventor based in Weehawken, NJ (US). She has made significant contributions to the field of stem cell research, particularly in the differentiation of stem cells into proprioceptors. Her work holds promise for advancing treatments for neurodegenerative disorders.

Latest Patents

Nadja Zeltner holds a patent titled "Methods of differentiating stem cell-derived proprioceptors." This patent outlines in vitro methods for inducing the differentiation of human stem cells into proprioceptors. The disclosed methods also include the use of these proprioceptors for preventing and treating disorders related to proprioceptor neurons and neurodegenerative conditions, such as Friedreich's Ataxia.

Career Highlights

Zeltner is affiliated with the Memorial Sloan Kettering Cancer Center, where she conducts her research. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in regenerative medicine.

Collaborations

Nadja Zeltner collaborates with Lorenz Studer, a fellow researcher in the field. Their partnership enhances the potential for groundbreaking discoveries in stem cell applications.

Conclusion

Nadja Zeltner's work in stem cell differentiation is paving the way for new therapeutic strategies in treating neurodegenerative disorders. Her contributions are vital to the ongoing research in this important area of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…